The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
Open accessAbstract
Liposomes are closed bilayer structures spontaneously formed by hydrated phospholipids that are widely used as efficient delivery systems for drugs or antigens, due to their capability to encapsulate bioactive hydrophilic, amphipathic, and lipophilic molecules into inner water phase or within lipid leaflets. The efficacy of liposomes as drug or antigen carriers has been improved in the last years to ameliorate pharmacokinetics and capacity to release their cargo in selected target organs or cells. Moreover, different formulations and variations in liposome composition have been often proposed to include immunostimulatory molecules, ligands for specific receptors, or stimuli responsive compounds. Intriguingly, independent research has unveiled the capacity of several phospholipids to play critical roles as intracellular messengers in modulating both innate and adaptive immune responses through various mechanisms, including (i) activation of different antimicrobial enzymatic pathways, (ii) driving the fusion-fission events between endosomes with direct consequences to phagosome maturation and/or to antigen presentation pathway, and (iii) modulation of the inflammatory response. These features can be exploited by including selected bioactive phospholipids in the bilayer scaffold of liposomes. This would represent an important step forward since drug or antigen carrying liposomes could be engineered to simultaneously activate different signal transduction pathways and target specific cells or tissues to induce antigen-specific T and/or B cell response. This lipid-based host-directed strategy can provide a focused antimicrobial innate and adaptive immune response against specific pathogens and offer a novel prophylactic or therapeutic option against chronic, recurrent, or drug-resistant infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Ovalbumin-Liposome Conjugate Induces IgG but Not IgE Antibody Production
Naito, S., Horino, A., Nakayama, M., et al. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237241 · Cited by 31
Perri, V., Pellegrino, M., Ceccacci, F., Scipioni, A., Petrini, S., Gianchecchi, E., Russo, A. L., Santis, S. D., Mancini, G., & Fierabracci, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175784 · Cited by 30
Guo, J. T., Waknine-Grinberg, J. H., Mitchell, A. J., Barenholz, Y., & Golenser, J. (2014) · BioMed Research International · doi:10.1155/2014/292471 · Cited by 28
Bupivacaine Versus Liposomal Bupivacaine For Pain Control
Beiranvand, S., & Moradkhani, M. R. (2017) · Drug Research · doi:10.1055/s-0043-121142 · Cited by 28
Ternullo, S., de Weerd, L., Holsæter, A. M., Flaten, G. E., & Škalko‐Basnet, N. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.09.006 · Cited by 24
Frezza, T. F., de Souza, A. L. R., Prado, C. C. R., de Oliveira, C. N. F., Gremião, M. P. D., Giorgio, S., Dolder, M. A. H., Joazeiro, P. P., & Allegretti, S. M. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.07.022 · Cited by 22
Mariotti, S., Pardini, M., Teloni, R., Gagliardi, M. C., Fraziano, M., & Nisini, R. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23268 · Cited by 20
Self-citationTaus, F., Santucci, M. B., Greco, E., Morandi, M., Palucci, I., Mariotti, S., Poerio, N., Nisini, R., Delogu, G., & Fraziano, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127279 · Cited by 19
Self-citationHebishima, T., Yuba, E., Kono, K., Takeshima, S., Ito, Y., & Aida, Y. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00273-12 · Cited by 19
si RNA ‐loaded liposomes: Inhibition of encystment of Acanthamoeba and toxicity on the eye surface
Faber, K., Zorzi, G. K., Brazil, N. T., Rott, M. B., & Teixeira, H. F. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12958 · Cited by 17
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis?
Garg, S. K., Santucci, M. B., Panitti, M., Pucillo, L. P., Bocchino, M., Okajima, F., Bisen, P. S., Saltini, C., & Fraziano, M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.09.002 · Cited by 14
Self-citationTakagi, A., Kobayashi, N., Taneichi, M., Uchida, T., & Akatsuka, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.028 · Cited by 13
Liposomes for the Delivery of Streptokinase
Kumar, L., Verma, S., & Vaidya, B. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0026 · Cited by 8
Delogu, G., Sali, M., Rocca, S., Quintiliani, G., Santucci, M. B., Greco, E., Cabibbo, A., Mariani, F., Colizzi, V., Fadda, G., et al. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.05.014 · Cited by 4
Self-citation
Cited by
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi, S., Nayak, A. K., & Behera, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110708 · Cited by 726
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Overcoming skin barriers through advanced transdermal drug delivery approaches
Phatale, V., Vaiphei, K. K., Jha, S., Patil, D., Agrawal, M., & Alexander, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.025 · Cited by 482
Németh, Z., Csóka, I., Semnani Jazani, R., Sipos, B., Haspel, H., Kozma, G., Kónya, Z., & Dobó, D. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091798 · Cited by 452
Metadata
- Authors
- Nisini, R., Poerio, N., Mariotti, S., De Santis, F., & Fraziano, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-02-05
- Volume
- 9
- Pages
- 155-155
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2794370011
- Cited by
- 296
- References
- 214
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.